Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Werewolf Therapeutics (HOWL) Accounts Payables (2021 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Accounts Payables for 5 consecutive years, with $754000.0 as the latest value for Q4 2025.

  • Quarterly Accounts Payables fell 75.16% to $754000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $754000.0 through Dec 2025, down 75.16% year-over-year, with the annual reading at $754000.0 for FY2025, 75.16% down from the prior year.
  • Accounts Payables for Q4 2025 was $754000.0 at Werewolf Therapeutics, down from $1.1 million in the prior quarter.
  • The five-year high for Accounts Payables was $3.2 million in Q2 2021, with the low at $754000.0 in Q4 2025.
  • Average Accounts Payables over 5 years is $1.7 million, with a median of $1.5 million recorded in 2021.
  • The sharpest move saw Accounts Payables soared 127.17% in 2024, then tumbled 75.16% in 2025.
  • Over 5 years, Accounts Payables stood at $2.0 million in 2021, then plummeted by 40.06% to $1.2 million in 2022, then rose by 9.42% to $1.3 million in 2023, then surged by 127.17% to $3.0 million in 2024, then crashed by 75.16% to $754000.0 in 2025.
  • According to Business Quant data, Accounts Payables over the past three periods came in at $754000.0, $1.1 million, and $2.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.